Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.

Cho, Hyun Jin

Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy. [electronic resource] - Surgical oncology Dec 2015 - 329-34 p. digital

Publication Type: Journal Article; Review

1879-3320

10.1016/j.suronc.2015.09.001 doi


Adenocarcinoma--drug therapy
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--metabolism
Carcinoma, Adenosquamous--drug therapy
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Chemoradiotherapy
Cisplatin--administration & dosage
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Immunoenzyme Techniques
Inhibitor of Apoptosis Proteins--metabolism
Lung Neoplasms--drug therapy
Lymph Node Excision
Male
Middle Aged
Neoplasm Invasiveness
Neoplasm Recurrence, Local--pathology
Neoplasm Staging
Paclitaxel--administration & dosage
Prognosis
Retrospective Studies
Survival Rate
Survivin